Three years after enrolling its first patients, a consortium of researchers examining the growing issue of immune-related adverse events due to immune checkpoint inhibitor cancer therapy released a ...
Amgen Inc. ( AMGN) Q4 2025 Earnings Call February 3, 2026 4:30 PM EST ...
Amgen Inc. delivered strong operational performance across the board in 2025, and you can see that in the breadth of our business. Three of these, Repatha, Evenity, and TestSpire, all grew by more ...
Correspondence to Professor Leonardo Azevedo Mobilia Alvares, Unidade de Endocrinologia do Desenvolvimento, Universidade de São Paulo Hospital das Clínicas, Sao Paulo, 05403-000, Brazil; leo_a_alvares ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results